Nabil Shabshab - Feb 28, 2023 Form 4 Insider Report for Inogen Inc (INGN)

Role: CEO and President, Director
Signature: /s/ Leslyn Cicekli, as Attorney-in-Fact
Stock symbol: INGN
Transactions as of: Feb 28, 2023
Transactions value $: -$190,377
Form type: 4
Date filed: 3/2/2023, 06:41 PM
Previous filing: Dec 5, 2022
Next filing: Jun 5, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INGN	Common Stock	Award	$0	+7.81K	+36.79%	$0.00	29K	Mar 1, 2023	Direct	F1
transaction	INGN	Common Stock	Tax liability	-$60.3K	-3.87K	-13.34%	$15.56	25.2K	Mar 1, 2023	Direct	F2
transaction	INGN	Common Stock	Options Exercise	$0	+16.7K	+66.38%	$0.00	41.9K	Mar 1, 2023	Direct
transaction	INGN	Common Stock	Tax liability	-$130K	-8.36K	-19.97%	$15.56	33.5K	Mar 1, 2023	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INGN	Restricted Stock Unit	Options Exercise	$0	-1.57K	-16.66%	$0.00	7.84K	Mar 1, 2023	Common Stock	1.57K		Direct	F4, F5
transaction	INGN	Restricted Stock Unit	Options Exercise	$0	-2.12K	-20%	$0.00	8.47K	Mar 1, 2023	Common Stock	2.12K		Direct	F4, F6
transaction	INGN	Restricted Stock Unit	Options Exercise	$0	-13K	-33.33%	$0.00	26K	Mar 1, 2023	Common Stock	13K		Direct	F4, F7
transaction	INGN	Restricted Stock Unit	Award	$0	+70.2K		$0.00	70.2K	Feb 28, 2023	Common Stock	70.2K		Direct	F4, F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported securities represent shares earned and vested on March 1, 2023 based on achievement of the financial performance conditions for the 2022 fiscal year that were approved as part of the 2022 performance-based restricted stock award granted on March 1, 2022.
F2	The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with the 2022 performance-based restricted stock award granted on March 1, 2022 and vested on March 1, 2023.
F3	The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2023.
F4	Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
F5	Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years.
F6	Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years.
F7	Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date.
F8	Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2024, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date.